𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study

✍ Scribed by Shinji Iwasaki; Hiromasa Ohira; Shuhei Nishiguchi; Mikio Zeniya; Shuichi Kaneko; Morikazu Onji; Hiromi Ishibashi; Isao Sakaida; Shigeki Kuriyama; Takafumi Ichida; Saburo Onishi; Gotaro Toda; Study Group of Intractable Liver Diseases for Research on a Specific Disease; Health Science Research Grant; Ministry of Health; Labour; Welfare of Japan

Book ID
118087928
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
214 KB
Volume
38
Category
Article
ISSN
1386-6346

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The combination of ursodeoxycholic acid
The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: The results of a pilot study
✍ Keith D. Lindor; E. Rolland Dickson; Roberta A. Jorgensen; Monte L. Anderson; Ru πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 553 KB

Ursodeoxycholic acid (UDCA) and methotrexate (MTX) have both been proposed as treatments for patients with primary biliary cirrhosis (PBC). It has been suggested that a combination of the two drugs may offer advantages over either used separately. In this pilot study, we sought to evaluate the safet